UAVenture Capital, LLC has announced the launch of a fund to support the commercialization of University of Arizona science, services and intellectual property. UAVC was formed by Fletcher J. McCusker, the business driver behind the UA College of Pharmacy startup SinfoníaRx.

UA startup SinfoníaRx has been acquired by Tabula Rasa HealthCare (NASDAQ: TRHC), provider of individualized, data-driven technology solutions. Spun out of the College of Pharmacy in 2013, SinfoníaRx pioneered modern medication therapy management (MTM) services.

In October, the Arizona Bioindustry Association, or AZBio, will honor industry leaders from across Arizona. This year, a majority of those to be honored have deep connections to the UA and have created impact through bringing UA ideas and inventions to the marketplace.

The University of Arizona has licensed a new non-skin penetrating sunscreen, invented by UA Professor Douglas Loy and graduate student Stephanie Tolbert, to MexiAloe Laboratorios, S.A. de C.V., a subsidiary of Novamex.

The UA center will use the funding to accelerate development of a Valley fever vaccine for dogs that one day may lead to a successful human vaccine.

Since TLA started in 2012, we have met or exceeded our goals year over year, and are seeing continued growth in the impact originally envisioned for commercialization at the UA. We did it again in FY2017 thanks to your engagement as inventors, experts, advisors and supporters.